

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Evinacumab iyimithi ekhethekile ejovwayo eyenzelwe ukwehlisa amazinga e-cholesterol aphezulu kakhulu kubantu abanesimo esingavamile sezakhi zofuzo esibizwa ngokuthi i-homozygous familial hypercholesterolemia (HoFH). Lokhu kwelashwa okunamandla kusebenza ngendlela ehlukile kunemithi ejwayelekile ye-cholesterol ngokuvimba iphrotheni ethile evimbela umzimba wakho ukuthi ungakhiphi i-cholesterol embi egazini lakho.
Uma wena noma othile omkhathalelayo etholiwe ukuthi une-HoFH, cishe uzizwa ukhungathekile ngamagama ezokwelapha nezinketho zokwelapha. Le mithi imelela ukuqanjwa okukhulu kwabantu abamazinga e-cholesterol ahlala ephakeme ngendlela eyingozi naphezu kokuzama ezinye izindlela zokwelapha.
I-Evinacumab iyimithi ye-monoclonal antibody eqondise iphrotheni ebizwa nge-ANGPTL3 (angiopoietin-like protein 3). Le phrotheni ngokuvamile iphazamisa ikhono lomzimba wakho lokwehlisa amafutha ne-cholesterol egazini lakho.
Cabanga nge-ANGPTL3 njengebhegi elinciphisa uhlelo lomzimba wakho lokususa i-cholesterol ngokwemvelo. I-Evinacumab ikhulula leyo bhegi, ivumela umzimba wakho ukuthi usebenze futhi ususe i-cholesterol ngempumelelo enkulu. Le mithi yenzelwe ngokuqondile abantu abane-homozygous familial hypercholesterolemia, isimo esingavamile sezakhi zofuzo esithinta cishe umuntu oyedwa kwabangu-300,000 emhlabeni jikelele.
Imithi iza njengesixazululo esicacile, esingenambala esinikezwa nge-intravenous (IV) infusion ngokuqondile egazini lakho. Le ndlela yokulethwa iqinisekisa ukuthi imithi ifinyelela ohlelweni lwakho ngokushesha futhi isebenza ngamandla agcwele.
I-Evinacumab ivunyelwe ngokuqondile ukwelapha i-homozygous familial hypercholesterolemia (HoFH) kubantu abadala kanye nezingane ezineminyaka engu-12 nangaphezulu. I-HoFH yisimo esibucayi sezakhi zofuzo lapho bobabili abazali bedlulisela izakhi zofuzo ezingalungile ezilawula ukucutshungulwa kwe-cholesterol.
Abantu abane-HoFH ngokuvamile banamazinga e-cholesterol ye-LDL aphakeme ngokuphindwe izikhathi eziyi-4-6 kunokujwayelekile, ngokuvamile adlula i-400-500 mg/dL. Lawa mazinga aphakeme kakhulu angaholela ekuhlaselweni yinhliziyo, ukushaywa unhlangothi, nezinye izinkinga zenhliziyo nemithambo yegazi esemncane kakhulu, ngezinye izikhathi ngisho nasebuntwaneni noma eminyakeni yobusha.
Udkt wakho ngokuvamile uzoqoka i-evinacumab lapho ezinye izindlela zokwelapha ezinciphisa i-cholesterol zingasebenzi ngokwanele. Lokhu kuhlanganisa izimo lapho ama-statins, ama-PCSK9 inhibitors, neminye imithi ingazange yehlise i-cholesterol yakho iye emazingeni aphephile.
Lo muthi usetshenziswa kanye nezinguquko zokudla kanye neminye imithi yokwehlisa ama-lipid njengengxenye yohlelo lokwelapha olubanzi. Akuhloselwe ukuthi ithathe indawo yokwelashwa okunye kodwa kunalokho ukusebenza ndawonye nabo ukuze kusebenze kahle.
I-Evinacumab isebenza ngokuvimba i-ANGPTL3, iphrotheni evame ukuvimbela umzimba wakho ukuthi ungahlukanisi ama-triglycerides ne-cholesterol ngempumelelo. Lapho le phrotheni ivalekile, umzimba wakho ungasusa amafutha emithanjeni yakho yegazi ngempumelelo enkulu.
Lona umuthi onamandla kakhulu mayelana nokunciphisa i-cholesterol. Izifundo zomtholampilo zibonisa ukuthi inganciphisa i-cholesterol ye-LDL ngamaphesenti angama-47% ngokwesilinganiso, okukhulu kubantu abangazange basabele kahle kwezinye izindlela zokwelapha.
Ngokungafani nama-statins asebenza esibindini sakho ukunciphisa ukukhiqizwa kwe-cholesterol, i-evinacumab isebenza emithanjeni yakho yegazi ukusiza ukususa i-cholesterol esivele ijikeleza. Le ndlela ephindwe kabili yingakho ivame ukusetshenziswa kanye neminye imithi kunokuthi ithathe indawo yayo ngokuphelele.
Imiphumela yomuthi ihlala isikhathi eside, ngokuqiniswa ngakunye okunikeza izinzuzo zokwehlisa i-cholesterol cishe inyanga. Lesi senzo esandisiwe sisho ukuthi ngeke udinge ukulinganisa njalo, okungenza ukuphatha ukwelashwa kwakho kube lula.
I-Evinacumab inikezwa njenge-infusion ye-intravenous njalo emavikini amane endaweni yokunakekelwa kwezempilo noma isikhungo se-infusion. Umthamo ojwayelekile ungama-15 mg ngekhilogramu ngalinye lesisindo somzimba wakho, onikezwa kancane kancane cishe imizuzu engama-60.
Akudingeki ukuthi uzile noma ugweme ukudla ngaphambi kwe-infusion yakho. Eqinisweni, ukudla ukudla okulula ngaphambi kwesikhathi kungakusiza ukuthi uzizwe ukhululekile ngesikhathi sokwelashwa. Ukuhlala unamanzi kahle ngokuphuza amanzi amaningi ngaphambi nangemva kwe-infusion yakho nakho kuyasiza.
Ithimba lakho lokunakekelwa kwezempilo lizokuqapha eduze ngesikhathi se-infusion ngayinye nangemva kwemizuzu okungenani engama-30. Bazohlola izimpawu zakho ezibalulekile futhi baqaphele noma yiziphi izindlela zokuphendula ngokushesha. Igumbi le-infusion livame ukuba lithokomele, futhi ungaletha izincwadi, amaphilisi, noma eminye imisebenzi ethule ukuze udlulise isikhathi.
Ngaphambi kwe-infusion ngayinye, umhlinzeki wakho wezempilo angase akunikeze imithi yokuvimbela ukusabela komzimba. Lokhu kungabandakanya ama-antihistamines noma ama-corticosteroids, kuye ngezidingo zakho ngazinye kanye nomlando wezokwelapha.
I-Evinacumab ngokuvamile ithathwa njengokwelashwa kwesikhathi eside sokuphatha i-homozygous familial hypercholesterolemia. Njengoba i-HoFH iyisimo sezakhi zofuzo esiphila impilo yonke, abantu abaningi badinga ukwelashwa okuqhubekayo ukuze bagcine amazinga abo e-cholesterol elawulwa.
Udokotela wakho uzohlola njalo amazinga akho e-cholesterol, ngokuvamile njalo emavikini ama-3-6, ukuze ahlulele ukuthi imithi isebenza kahle kangakanani. Bazophinda bahlole noma yiziphi izinto ezingezinhle futhi balungise uhlelo lwakho lokwelashwa olujwayelekile njengoba kudingeka.
Isinqumo mayelana nokuqhubeka nokwelashwa sincike ezintweni eziningana: ukuthi amazinga akho e-cholesterol aphendula kahle kangakanani, ukuthi ngabe uhlangabezana nanoma yiziphi izinto ezingezinhle ezibalulekile, kanye nesimo sakho sempilo esijwayelekile. Abanye abantu bangase badinge ukuqhubeka nokwelashwa unomphela, kanti abanye bangase bakwazi ukunciphisa imvamisa noma bazame ezinye izindlela ngokuhamba kwesikhathi.
Ungayeki ukuthatha i-evinacumab ngokuzumayo ngaphandle kokuxoxa nodokotela wakho kuqala. Amazinga akho e-cholesterol angakhuphuka ngokushesha, okungenzeka kukubeke engozini eyengeziwe yezinkinga zenhliziyo nemithambo yegazi.
Abantu abaningi bayayibekezelela kahle i-evinacumab, kodwa njengayo yonke imithi, ingabangela imiphumela emibi. Izimo ezivamile ngokuvamile zithambile futhi zilawuleka ngokugadwa nokunakekelwa okufanele.
Nansi imiphumela emibi ongase uyithole, ukhumbula ukuthi abantu abaningi banenkinga encane noma abanayo ngalo muthi:
Le miphumela emibi ejwayelekile ivame ukuthuthuka yodwa ezinsukwini ezimbalwa futhi iba ngaphansi uma umzimba wakho ujwayela umuthi.
Nakuba kungavamile, kunezinye izimo ezingezinhle ezingathi sína ezidinga ukunakekelwa kwezokwelapha ngokushesha:
Iqembu lakho lezempilo liyazi ukuthi lingawabona futhi liwalawule kanjani lawa ma-reaction ngokushesha. Bazohlala benemithi ephuthumayo etholakalayo ngesikhathi sokufakwa kwakho futhi bazokufundisa ukuthi yiziphi izimpawu zokuxwayisa okufanele uzibheke ekhaya.
I-Evinacumab ayifanele wonke umuntu, futhi zikhona izimo ezithile lapho udokotela wakho ezokuncoma ukuthi ungayisebenzisi le mithi. Into ebaluleke kakhulu ukuba nokuxilongwa okuqinisekisiwe kwe-homozygous familial hypercholesterolemia, njengoba le mithi yenzelwe ngqo lesi simo esingavamile.
Akufanele uthole i-evinacumab uma uke waba ne-allergic reaction enkulu kule mithi noma kunoma iyiphi yezingxenye zayo esikhathini esidlule. Izimpawu zalezi zimo zihlanganisa ubunzima bokuphefumula, ukuvuvukala okukhulu, noma ukusabela kwesikhumba okusabalale okudinga ukwelashwa okuphuthumayo.
Udokotela wakho uzohlola ngokucophelela ukuthi le mithi ikufanele yini uma unezimo ezithile zempilo:
Izingane ezingaphansi kweminyaka engu-12 ubudala akufanele zithole i-evinacumab, njengoba ukuphepha nokusebenza kungakazinziswa kulolu hlu lweminyaka. Kodwa-ke, ucwaningo luqhubeka ukuze kutholakale ukuthi kungase kuphephe futhi kusebenze ezinganeni ezincane ezinama-HoFH.
Uma uthatha eminye imithi, ikakhulukazi leyo ethinta amasosha akho omzimba noma ukusebenza kwesibindi, udokotela wakho uzodinga ukubuyekeza yonke imithi yakho ngokucophelela ngaphambi kokuqala i-evinacumab.
I-Evinacumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Evkeeza e-United States nakwamanye amazwe amaningi. Leli okwamanje yilo kuphela igama lomkhiqizo elitholakala kule mithi.
Igama eliphelele elivamile lithi evinacumab-dgnb, okusiza ukuthi lihlukaniswe kwamanye ama-antibody e-monoclonal angase athuthukiswe esikhathini esizayo. Uma uthola imithi yakho, uzobona "Evkeeza" emaphaketheni nasezikhwameni zokufaka.
Njengoba le yimithi entsha uma iqhathaniswa nezinye, eyavunywa okokuqala ngqa ngo-2021, azikho izinhlobo ezivamile ezitholakalayo okwamanje. Le mithi yenziwa yi-Regeneron Pharmaceuticals futhi isatshalaliswa ngezitolo zemithi ezikhethekile kanye nezikhungo zokufaka.
Ngenkathi i-evinacumab yenzelwe ngqo i-homozygous familial hypercholesterolemia, zikhona ezinye izindlela zokwelapha udokotela wakho angazicabangela ngokuya ngesimo sakho esithile nokuthi usabela kanjani emithini ehlukene.
Imithi yokwehlisa i-cholesterol yendabuko evame ukusetshenziswa kanye noma esikhundleni se-evinacumab ihlanganisa ama-statins amaningi afana ne-atorvastatin noma i-rosuvastatin. Lezi zisebenza ngokunciphisa ukukhiqizwa kwe-cholesterol esibindini sakho, yize ngokuvamile zingaqini ngokwanele zodwa ze-HoFH.
Izithiyo ze-PCSK9 ezifana ne-evolocumab (Repatha) noma i-alirocumab (Praluent) zimelela enye inketho yemithi ejovwayo enganciphisa kakhulu i-cholesterol. Lezi zisebenza ngendlela ehlukile ku-evinacumab futhi ngezinye izikhathi zisetshenziswa ngokuhlangana nayo.
Kwabanye abantu abane-HoFH, i-LDL apheresis ingase ibe yindlela. Lena inqubo efana ne-dialysis lapho igazi lakho lihlungwa khona ukuze kususwe i-cholesterol ngqo. Ngokuvamile kwenziwa njalo ngemva kwamasonto angu-1-2 futhi kungasebenza kahle kakhulu, yize kuthatha isikhathi esiningi kunemithi.
Eminye imithi engaba yingxenye yohlelo lwakho lokwelapha ihlanganisa i-ezetimibe (Zetia), evimbela ukumuncwa kwe-cholesterol emathunjini akho, kanye nama-bile acid sequestrants afana ne-colesevelam (Welchol).
I-Evinacumab kanye nezithiyo ze-PCSK9 zisebenza ngezindlela ezihlukene, ngakho ukuqathanisa ngqo akulula. Zombili ziyimithi enamandla yokwehlisa i-cholesterol, kodwa zivame ukusetshenziswa ezimweni ezihlukene noma ngisho ndawonye.
Izithiyo ze-PCSK9 ngokuvamile zizanywa kuqala ngoba seziqhamuke isikhathi eside futhi zinolwazi oluningi lokuphepha. Zivunyelwe futhi ukusetshenziswa ezinhlobonhlobo zezimo ze-cholesterol, hhayi nje i-HoFH. Le mithi inganciphisa i-cholesterol ye-LDL ngamaphesenti angama-50-60% kubantu abaningi.
I-Evinacumab inikeza ezinye izinzuzo ezihlukile kubantu abane-HoFH. Isebenza ngisho nalapho izamukeli ze-LDL zingasebenzi kahle, okuyinto evame ukwenzeka ku-HoFH. Lokhu kuyenza isebenze kubantu abangaphenduli kahle ezithiyweni ze-PCSK9 noma kuma-statins.
Ukukhetha phakathi kwale mithi kuncike ohlotsheni lwakho oluthile lwe-HoFH, ukuthi uphendule kanjani kwezinye izindlela zokwelapha, kanye nezici zakho zempilo. Abantu abaningi empeleni basebenzisa zombili izinhlobo zemithi ndawonye ukuze kuncishiswe i-cholesterol ngokugcwele.
Udokotela wakho uzocabangela izici ezinjengamazinga akho e-cholesterol njengamanje, izimpendulo zokwelashwa zangaphambilini, izici zokuphila, kanye nezintandokazi zomuntu siqu lapho enquma ukuthi iyiphi indlela engcono kakhulu kuwe.
I-Evinacumab ngokuvamile iphephile kubantu abanesifo sikashukela, futhi ukuba nesifo sikashukela akukuvimbeli ukuthi usebenzise le mithi. Eqinisweni, abantu abane-HoFH kanye nesifo sikashukela bavame ukudinga ukuphathwa kwe-cholesterol okunobudlova ngoba isifo sikashukela sikhulisa ingozi yenhliziyo nemithambo yegazi.
Udokotela wakho uzoqapha amazinga akho kashukela egazini eduze lapho uqala i-evinacumab, njengoba abanye abantu behlangabezana nezinguquko ezincane ekulawuleni i-glucose. Lezi zinguquko zivame ukuba zincane futhi zilawuleka ngokulungiswa kwemithi yakho yesifo sikashukela uma kudingeka.
Izinzuzo zenhliziyo nemithambo yegazi zokwehlisa i-cholesterol ephezulu ngokwedlulele ngokuvamile zidlula noma yimiphi imiphumela emincane esezingeni likashukela wegazi. Ithimba lakho lokunakekelwa kwezempilo lizosebenza nawe ukuze uthuthukise kokubili i-cholesterol yakho nokuphathwa kwesifo sikashukela ngasikhathi sinye.
Uma uphuthelwa ukufakwa kwe-evinacumab okuhleliwe, xhumana nomhlinzeki wakho wezempilo noma isikhungo sokufaka ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Ungalindi kuze kube yilapho uqokwe khona okulandelayo njalo, njengoba ukuphuthelwa imithamo kungavumela amazinga akho e-cholesterol ukuthi anyuke.
Ngokuvamile, uma uphuthelwa umthamo ngezinsuku ezimbalwa nje, ungalithola ukufakwa bese uqhubeka nohlelo lwakho lwanyanga zonke olujwayelekile. Uma uphuthelwa umthamo ngaphezu kwesonto elilodwa, udokotela wakho angase afune ukuhlola amazinga akho e-cholesterol ngaphambi kokunquma ukuthi uzolifaka nini elilandelayo.
Zama ukuhlela kabusha phakathi nezinsuku ezimbalwa zokuqokwa kwakho okungaphuthelwanga uma kungenzeka. Ithimba lakho lokunakekelwa kwezempilo liyaqonda ukuthi ngezinye izikhathi kuvela izingxabano zokuhlela futhi lizosebenza nawe ukuthola ukuqokwa okulula.
Uma uthola imiphumela emibi engathi sína ngesikhathi sokufakwa kwakho, ithimba lokunakekelwa kwezempilo lizoyeka ukufakwa ngokushesha futhi linikeze ukwelashwa okufanele. Baqeqeshwe ukuphatha ukusabela kokufakwa futhi banemithi esheshayo etholakalayo.
Ngemiphumela emibi engathi sína eyenzeka ngemva kokuthi ushiye isikhungo sokufaka, njengobunzima bokuphefumula, ukuvuvukala okukhulu, noma izimpawu zokungezwani komzimba okungathi sína, funa ukunakekelwa kwezempilo okuphuthumayo ngokushesha. Ungalindi ukubona ukuthi izimpawu ziyathuthuka zodwa.
Ngemiphumela emibi engathi sína kodwa ekhathazayo evela phakathi kokufakwa, xhumana nomhlinzeki wakho wezempilo ngamahora ebhizinisi ajwayelekile. Bangasiza ukunquma ukuthi izimpawu zihlobene yini nomuthi nokuthi yiziphi izinyathelo okufanele zithathwe ngokulandelayo.
Isinqumo sokuyeka ukusebenzisa i-evinacumab kufanele senziwe ngaso sonke isikhathi ngokubonisana nodokotela wakho. Njengoba i-HoFH iyisimo sezinto eziphilayo esihlala impilo yonke, abantu abaningi badinga ukwelashwa okuqhubekayo ukuze bagcine amazinga e-cholesterol aphephile.
Udokotela wakho angase acabange ukuyeka noma ukunciphisa ukwelashwa uma uhlangabezana nemiphumela emibi ebalulekile edlula izinzuzo, uma amazinga akho e-cholesterol elawulwa kahle ngeminye imithi, noma uma izinketho zokwelashwa ezintsha zitholakala.
Abanye abantu bangase bakwazi ukuhlukanisa izikhathi zabo zokufakwa kwemithi uma amazinga abo e-cholesterol esezinzile, kodwa lokhu kuncike ekuphenduleni komuntu ngamunye futhi kufanele kwenziwe ngaphansi kokuqondiswa kwezokwelapha.
Yebo, ngokuvamile ungafaka imigomo ngenkathi uthatha i-evinacumab. Le mithi ayicindezeli kakhulu amasosha akho omzimba njengeminye imithi, ngakho ukugonywa okuvamile kuvame ukuphepha futhi kunconywa.
Noma kunjalo, kungcono ngaso sonke isikhathi ukwazisa umhlinzeki wakho wezempilo nganoma iyiphi imigomo ohlela ukuyithola. Bangase bancomise ukuhlela imigomo phakathi kokufakwa kwemithi noma ukukuqapha eduze ngemva kwalokho, ikakhulukazi ngemigomo ephilayo.
Ukuhlala usesikhathini nemigomo enconyiwe kubaluleke kakhulu kubantu abanezimo ezingapheli njenge-HoFH, njengoba izifo ngezinye izikhathi zingase zithuthukise impilo yenhliziyo nemithambo yegazi okwesikhashana.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.